Effects of modafinil, caffeine and methylphenidate on functional brain activity and cognitive performance in healthy volunteers: a randomized, placebo-controlled, double-blind fMRI study.

Trial Profile

Effects of modafinil, caffeine and methylphenidate on functional brain activity and cognitive performance in healthy volunteers: a randomized, placebo-controlled, double-blind fMRI study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Sep 2016

At a glance

  • Drugs Caffeine (Primary) ; Methylphenidate (Primary) ; Modafinil (Primary)
  • Indications Apnoea; Attention-deficit hyperactivity disorder; Narcolepsy
  • Focus Pharmacodynamics
  • Acronyms MKM
  • Most Recent Events

    • 16 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 24 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top